Evaluation of early atherosclerotic findings in women with polycystic ovary syndrome

Journal of Ovarian Research

Volumn 4, Issue 1, 2011, Pages

  Mohammadi, Afshin ^a   Aghasi, Mohammadreza ^a   Jodeiry Farshbaf, Leila ^a   Salary Lac, Shaker ^a   Ghasemi Rad, Mohammad ^a  

^a URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; HYDROXYPROGESTERONE; INSULIN; LUTEINIZING HORMONE; PRASTERONE SULFATE; PROLACTIN; SEX HORMONE; TESTOSTERONE;

ADULT; ARTERIAL WALL THICKNESS; ARTERY DILATATION; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

EID: 80054814981     PISSN: None     EISSN: 17572215     Source Type: Journal    
DOI: 10.1186/1757-2215-4-19     Document Type: Article

References (27)

1. Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease. Baranova A, Tran TP, Birerdinc A, Younossi ZM, Aliment Pharmacol Ther 2011 33 7 801 14 10.1111/j.1365-2036.2011.04579.x 21251033
2. Insulin resistance, polycystic ovary syndrome and type 2 diabetes. Ovalle F, Azziz R, Fertil Steril 2002 77 1095 1105 10.1016/S0015-0282(02)03111-4 12057712 (Pubitemid 34626313)
3. Effect of severity of steatosis as assessed ultrasonographically on hepatic vascular indices in non-alcoholic fatty liver disease. Mohammadi A, Ghasemi-rad M, Zahedi H, Toldi G, Alinia T, Medical Ultrasonography 2011 13 3 200 206 21894290
4. Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease. Meyer C, McGrath BP, Teede HJ, J Clin Endocrinol Metab 2005 90 10 5711 6 10.1210/jc.2005-0011 16046590 (Pubitemid 41415480)
5. ET-B receptor contribution to peripheral microvascular functions in women with Polycystic Ovary Syndrome. Wenner MM, Taylor HS, Stachenfeld N, J Physiol 2011 8
6. Endothelial dysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low-grade chronic inflammation. Tarkun I, Arslan BC, Cantürk Z, Türemen E, Sahin T, Duman C, Journal of Clinical Endocrinology and Metabolism 2004 89 5592 5596 10.1210/jc.2004-0751 15531516 (Pubitemid 39518445)
7. Endothelial function varies according to insulin resistance disease type. Beckman JA, Goldfine AB, Dunaif A, Gerhard-Herman M, Creager MA, Diabetes Care 2007 30 5 1226 32 10.2337/dc06-2142 17261751 (Pubitemid 46684652)
8. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, Fertil Steril 2004 81 19 24 15126094
9. Diagnostic value of flow mediated dilatation measurement for coronary artery lesions in men under 45 years of age. Kamierski M, Michalewska-Wudarczyk A, Krzych LJ, Tendera M, Cardiol J 2010 17 3 288 92 20535720
10. Counterpoint: Flow-mediated dilation does not reflect nitric oxide-mediated endothelial function. Tschakovsky ME, Pyke KE, J Appl Physiol 2005 99 3 1235 8 10.1152/japplphysiol.00607.2005 16103525 (Pubitemid 41214546)
11. Clinical impact of vasomotor function assessment and the role of ACE-inhibitors and statins. Asselbergs FW, Van der harst P, Jessurum GA, Tio RA, Van Glist WH, Vascul Pharmacol 2005 42 3 125 40 10.1016/j.vph.2005.01.009 15792930 (Pubitemid 40417712)
12. Flow mediated dilation of the brachial artery: an investigation of methods requiring further standardization. Peretz A, Leota DF, Sullivan JH, Trenga CA, Sands FN, Aulet MR, Paun M, Gill EA, Kaufman JD, BMC Cardiovascular Disorder 2007 7 11 10.1186/1471-2261-7-11 (Pubitemid 46554384)
13. Insulin action in the vasculature: physiology and pathophysiology. Mather K, Anderson TJ, Verma S, J Vasc Res 2001 38 415 422 10.1159/000051074 11561143 (Pubitemid 34701454)
14. Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome. Orio F Jr, Palomba S, Cascella T, De Simone B, Di Biase S, Russo T, Labella D, Zullo F, Lombardi G, Colao A, J Clin Endocrinol Metab 2004 89 4588 4593 10.1210/jc.2003-031867 15356067 (Pubitemid 39244474)
15. Predictors of endothelial dysfunction in young women with polycystic ovary syndrome. Kravariti M, Naka KK, Kalantaridou SN, Kazakos N, Katsouras CS, Makrigiannakis A, Paraskevaidis EA, Chrousos GP, Tsatsoulis A, Michalis LK, J Clin Endocrinol Metab 2005 90 5088 5095 10.1210/jc.2005-0151 15985492 (Pubitemid 41262259)
16. Polycystic ovary syndrome is associated with endothelial dysfunction. Paradisi G, Steinberg HO, Hempfling A, Cronin J, Hook G, Shepard MK, Baron AD, Circulation 2001 103 1410 1415 11245645 (Pubitemid 32220633)
17. Intima-media thickness of elastic and muscular arteries in young women with polycystic ovaries. Lakhani K, Hardiman P, Seifalian A, Atherosclerosis 2004 175 353 359 10.1016/j.atherosclerosis.2004.04.007 15262192 (Pubitemid 38942916)
18. Evidence for the association between polycystic ovary syndrome and premature carotid atherosclerosis in middle aged women. Talbott E, Guzick D, Sutton-Tyrrell K, McHugh-Pemu P, Zborowski J, Remsberg K, Arterioscler Thromb Vasc Biol 2000 20 2414 2421 10.1161/01.ATV.20.11.2414 11073846
19. Polycystic ovarian syndrome is associated with endothelial dysfunction. Paradisi G, Steinberg H, Hempfling A, Cronin J, Hook G, Shepard M, Circulation 2001 103 1410 1415 11245645 (Pubitemid 32220633)
20. Normal endothelial function despite insulin resistance in healthy women with the polycystic ovary syndrome. Mather KJ, Verma S, Corenblum B, Anderson TJ, J Clin Endocrinol Metab 2000 85 1851 1856 10.1210/jc.85.5.1851 10843164 (Pubitemid 32269288)
21. Flow-mediated dilatation in overweight and obese women with polycystic ovary syndrome. Brinkworth GD, Noakes M, Moran LJ, Norman R, Clifton PM, BJOG 2006 113 11 1308 1314 10.1111/j.1471-0528.2006.01090.x 17059392 (Pubitemid 44581522)
22. Ultrasound examination of polycystic ovaries: is it worth counting the follicles? Jonard S, Robert Y, Cortet-Rudelli C, Pigny P, Decanter C, Dewwailly D, Hum Reprod 2003 18 3 598 603 10.1093/humrep/deg115 12615832 (Pubitemid 36329332)
23. Polycystic ovary sybdrome. Ehrmann DA, N Engl J Med 2005 352 12 1223 1236 10.1056/NEJMra041536 15788499 (Pubitemid 40397264)
24. Insulin resistance in healthy Mexican Americans is associated with coronary artery endothelial dysfunction. Quinones M, Pampaloni M, Juarez B, Diabetes 2000 49 146
25. Endothelial dysfunction is detectable in young normotensive first degree relatives of subjects with type II diabetes in association with insulin resistance. Balletshofer B, Rittig K, Enderle M, Circulation 2000 101 1780 1784 10769277 (Pubitemid 30213098)
26. Insulin causes endothelial dysfunction in humans. Arcaro G, Cretti A, Balzano S, Lechi A, Muggeo M, Bonora E, Circulation 2002 105 576 585 10.1161/hc0502.103333 11827922 (Pubitemid 34123431)
27. Vascular function and carotid intimal-medial thickness in children with insulin-dependent diabetes mellitus. Singh T, Groehn H, Kazmers A, J Am Coll Cardiol 2000 19 661 665